- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Melissa Andel Previews Her Upcoming Session on Drug Pricing Reform at AMCP 2022
Melissa Andel, principal at CommonHealth Solutions, previewed her session on policy making and pricing reform at the upcoming Academy of Managed Care Pharmacy's annual meeting.
Melissa Andel, principal at CommonHealth Solutions, previewed her session on policy making and pricing reform at the upcoming Academy of Managed Care Pharmacy's annual meeting.
Transcript
What will you be talking about during your session at AMCP 2022?
So, my session is just going to be an update on what's going on here in [Washington,] DC, mainly with regard to Congress, as well as what the Biden administration has been working on with respect to drug price reform. So, not just reconciliation, but also some of the administrative rules that HHS has, which also includes CMS and HRSA [Health Resources and Services Administration], and some of the actions that the Biden administration has been working on and what that means for patients and payers and manufacturers.
What other presentations are you looking forward to checking out at AMCP 2022?
Oh, yeah, so I've got a couple. I was filling out my agenda the other day. But yeah, there's a couple on digital therapeutics that I'm looking forward to and also a few on value-based purchasing contracts and 340B and the Medicaid pharmacy benefit that I'm looking forward to attending. So, the sessions that are on some of the newer trends that are facing payers and the industry are always interesting to me.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
